MolecureWAR:MOC +3.90%29 Market Cap is zł138.21 Mil as of Jun. 28, 2026. GuruFocus rates WAR:MOC with a GF Score™ of 29/100. The stock has 3 warning signs investors should review. Among 1,429 Biotechnology companies, Molecure ranks worse than 67.67% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Molecure's share price for the quarter that ended in Sep. 2025 was zł7.37. Molecure's Shares Outstanding (EOP) for the quarter that ended in Sep. 2025 was 20.60 Mil. Therefore, Molecure's market cap for the quarter that ended in Sep. 2025 was zł151.84 Mil.
Molecure's quarterly market cap
declined
from Mar. 2025 (zł185.46 Mil) to Jun. 2025 (zł110.84 Mil) but then
increased
from Jun. 2025 (zł110.84 Mil) to Sep. 2025 (zł151.84 Mil).
Molecure's annual market cap
increased
from Dec. 2022 (zł200.07 Mil) to Dec. 2023 (zł328.30 Mil) but then
declined
from Dec. 2023 (zł328.30 Mil) to Dec. 2024 (zł204.05 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Molecure's Enterprise Value for Today is zł121.33 Mil.
Molecure (WAR:MOC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Molecure Market Cap Related Terms
Molecure Market Cap Historical Data
* Premium members only.
The historical data trend for Molecure's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:MOC vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Molecure's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Molecure Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Molecure's Market Cap distribution charts can be found below:
* The bar in red indicates where Molecure's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Molecure's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Molecure (WAR:MOC) has a Market Cap of zł138.21 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Molecure and its competitors. According to the industry distribution chart, Molecure ranks #967 out of 1429 companies in the Biotechnology industry, placing it in the top 67.7%.
Is Molecure's Market Cap too high?
Molecure's current Market Cap is zł138.21 Mil. Based on the distribution chart, Molecure ranks #967 out of 1429 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Molecure has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Molecure's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Molecure ranks #967 out of 1429 companies for Market Cap. This places Molecure in the lower half of its industry. The industry median Market Cap is 112.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 112.70, based on 1,429 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Molecure and its competitors. For the Biotechnology industry, the median Market Cap is 112.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Molecure's current Market Cap is zł138.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecure stock overvalued right now?
Molecure (WAR:MOC) has a current Market Cap of zł138.21 Mil. The current Market Cap is zł138.21 Mil. Molecure's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Molecure (WAR:MOC), the current Market Cap is zł138.21 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Molecure SA is a biopharmaceutical company engaged in discovering, developing, and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.
29GF Score
Get the complete analysis for WAR:MOC
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MOC has been successfully added to your 
